Silexion Therapeutics Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SLXNW research report →
Price Chart
About the company
Silexion Therapeutics LTD is a biopharmaceutical company focused on the discovery and development of RNA interference (RNAi)-based therapies and their delivery systems, specifically targeting aggressive solid tumors. The firm utilizes its proprietary LODER delivery platform for the treatment of these malignant growths. Its pipeline features SiG12D-LODER, which has successfully completed preclinical investigations and an open-label Phase I clinical trial for pancreatic cancer.
- CEO
- Ilan Hadar
- IPO
- 2024
- Employees
- 14
- HQ
- Jerusalem, TA, IL
Get TickerSpark's AI analysis on SLXNW
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $8.41K
- P/E
- -0.01
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 6.23
- EV/EBITDA
- 0.05
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -276.59%
- ROIC
- 628.40%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $11.63M
- Net Income
- $-11,912,000+27.6%
- EPS
- $-89.60-239.4%
- OCF Growth
- -28.9%
- FCF Growth
- -28.6%
- 52W High
- $0.03
- 52W Low
- $0.01
- 50D MA
- $0.03
- 200D MA
- $0.03
- Beta
- -0.27
- RSI (14)
- 44
- Avg Volume
- 41.20K
No earnings-call transcripts are available for SLXNW yet.
- Free Float
- 100.0%
- Shares Outstanding
- 560.96K
- Float Shares
- 560.96K
of shares held by institutions
23 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Clear Street LLC | 219.76K | ▲ 74.60K |
| Cobblestone Capital Advisors LLC | 10.00K | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 4, 26 | Shirvan Mitchell | other | 6,000 |
| Jun 4, 26 | Horenshtein Hadar Mirit | other | 7,500 |
| Jun 4, 26 | Hadar Ilan | other | 10,000 |
| Mar 26, 26 | Shirvan Mitchell | sell | 22,818 |
| Feb 20, 26 | Noy Shlomo | other | 9,091 |
| Feb 20, 26 | Noy Shlomo | other | 10,685 |
| Feb 20, 26 | Alon Ruth | other | 10,685 |
| Feb 20, 26 | Alon Ruth | other | 9,091 |
| Feb 20, 26 | Shirvan Mitchell | other | 49,726 |
| Feb 20, 26 | Horenshtein Hadar Mirit | other | 49,726 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our SLXNW coverage
Recent articles, reports, and earnings notes.
No research on SLXNW yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SLXNW report →